To date, the expression of SLC6A14 is upregulated in estrogen receptor-positive breast cancer, cervical cancer, pancreatic cancer, and colorectal cancer [19–21, 24, 25]. Here, SLC6A14 is linked to familial pancreatic carcinoma.